Find help paying for Erivedge

The following resources are available to provide financial assistance.

Find Patient Assistance*

If you are eligible we have several options to help you pay for your medicine. Answer a few simple questions to find out which one might be right for you, using the Patient Assistance Tool below.

  • Are you insured?

  • Do you have commercial health insurance?

    What does this mean?
  • Are you already getting financial assistance to help pay for your medicine?

    What does this mean?
  • Are you over 18 years of age?

Genentech BioOncology Co-pay Card

This program might be able to help with the out-of-pocket costs of your medicine.

 

Click here to learn more about the Genentech BioOncology Co-pay Card.

Independent Co-pay Assistance Foundations

If you need help with medication co-pays, we can refer you to independent co-pay assistance foundations. Foundations have their own specific criteria.

 

Click here to learn more about independent co-pay assistance foundations.

The Genentech® Access to Care Foundation, or GATCF

GATCF helps qualified patients receive their medicine free of charge. To qualify for free medicine from GATCF, you need to meet specific criteria.

 

Click here to learn more about GATCF.

*Patients must meet certain criteria. 

The Genentech BioOncology Co-pay Card

Helping you connect with Erivedge

At Genentech, we are committed to helping patients access the treatment they have been prescribed.

That’s why we offer the Genentech BioOncology Co-pay Card. If you are eligible, this card can help assist with out-of-pocket costs like co-payments, co-insurance, or deductibles for your Erivedge treatment. Out-of-pocket costs are the part of your treatment that your healthcare plan requires you to pay.

Visit www.copayassistancenow.com or call 855-MYCOPAY (855-692-6729) from 9 AM – 8 PM ET, Monday through Friday.

Eligibility: Not available for patients covered by federally funded health insurance. Patients who purchase health insurance through a state or federal exchange pursuant to the ACA can qualify to use the Co-pay Card. 

What are the features of the card?

Your out-of-pocket costs can add up fast. That’s why we offer assistance.

 

Terms and Conditions

Use of the card does not obligate you to use or continue using any specific product or provider. If you have any questions regarding your eligibility or benefits, or if you wish to no longer be part of the program, contact Genentech BioOncology Co-pay Card at 855-MYCOPAY (855-692-6729).

You may receive additional program information about the Genentech BioOncology Co-pay Card once you are enrolled. Genentech BioOncology Access Solutions® can also activate this card for you.

No person or entity may seek reimbursement from any third-party payer for any amount provided using the card program. Use of this card must be consistent with all relevant health insurance requirements and payer agreements. Participating patients and pharmacies are obligated to inform third-party payers about this card as provided for under the applicable insurance or as otherwise required by contract or law. Genentech USA, Inc. reserves the right to deny payment under the card to anyone deemed ineligible in accordance with the stated program criteria.

Access Solutions

Referrals to Co-pay Foundations

If you do not qualify for the Genentech BioOncology Co-pay Card, Access Solutions might still be able to help. Access Solutions can connect you to a co-pay foundation to help you pay for Erivedge.

Access Solutions cannot guarantee you will get help from a co-pay foundation. The co-pay foundations each have their own rules, including financial rules. Genentech does not influence or control these co-pay foundations. But Erivedge Access Solutions can help you. We can refer you to an appropriate co-pay foundation. We can also help with the application process. 

Genentech® Access to Care Foundation

The Genentech Access to Care Foundation, or GATCF, helps people who have health insurance and those who don't. GATCF helps qualified patients receive their medicine free of charge.

During the enrollment process, you may be asked to provide details on the treatment prescribed by your doctor. Qualified patients must meet certain medical and financial criteria.

Please note that your enrollment in the program must be renewed every 12 months.
 

Important Safety Information

What is the most important information I should know about Erivedge?

  • Erivedge can cause your baby to die before it is born (be stillborn) or cause your baby to have severe birth defects

For females who can become pregnant:

  • You should talk with your healthcare provider about the risks of Erivedge to your unborn child
  • Your healthcare provider will do a pregnancy test before you start taking Erivedge
  • In order to avoid pregnancy, you should use birth control during treatment and for 24 months after your final dose of Erivedge. Talk with your healthcare provider about what birth control method is right for you during this time (continued below)

Please see additional Important Safety Information >

Get ongoing educational support during treatment.

Join today

Indication

Erivedge is a prescription medicine used to treat adults with a type of skin cancer, called basal cell carcinoma, that has spread to other parts of the body or that has come back after surgery or that your healthcare provider decides cannot be treated with surgery or radiation.

It is not known if Erivedge is safe and effective in children.

Serious Side Effects

Erivedge can cause your baby to die before it is born (be stillborn) or cause your baby to have severe birth defects.

Important Safety Information

What is the most important information I should know about Erivedge?

  • Erivedge can cause your baby to die before it is born (be stillborn) or cause your baby to have severe birth defects

For females who can become pregnant:

  • You should talk with your healthcare provider about the risks of Erivedge to your unborn child
  • Your healthcare provider will do a pregnancy test before you start taking Erivedge
  • In order to avoid pregnancy, you should use birth control during treatment and for 24 months after your final dose of Erivedge. Talk with your healthcare provider about what birth control method is right for you during this time
  • Talk to your healthcare provider right away if you have unprotected sex or if you think that your birth control has failed
  • Tell your healthcare provider right away if you become pregnant or think that you may be pregnant

For males:

  • Erivedge is present in semen. Do not donate semen while you are taking Erivedge and for 3 months after your final dose
  • You should always use a condom, even if you have had a vasectomy, during sex with female partners who are pregnant or who are able to become pregnant, during treatment with Erivedge, and for 3 months after your final dose to protect your female partner from being exposed to Erivedge
  • Tell your healthcare provider right away if your partner becomes pregnant or thinks she is pregnant while you are taking Erivedge

Exposure to Erivedge during pregnancy:

If you think that you or your female partner may have been exposed to Erivedge during pregnancy, talk to your healthcare provider right away. If you become pregnant during treatment with Erivedge, you or your healthcare provider should report your pregnancy to Genentech at (888) 835-2555.

What should I tell my healthcare provider before taking Erivedge?

  • If you are pregnant or plan to become pregnant
  • If you are breastfeeding or plan to breastfeed. It is not known if Erivedge passes into your breast milk. You should not breastfeed during treatment and for 24 months after your final dose of Erivedge. Talk to your healthcare provider about the best way to feed your baby during this time
  • About all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements

What should I avoid while taking Erivedge?

  • Do not donate blood or blood products while you are taking Erivedge and for 24 months after your final dose
  • Do not donate semen while you are taking Erivedge and for 3 months after your final dose

What are the possible side effects of Erivedge?

  • Bone growth problems. Bone growth problems have happened in children who have been exposed to Erivedge. These problems may continue even after stopping treatment with Erivedge
  • The most common side effects of Erivedge are:
    • Muscle spasms
    • Hair loss
    • Change in how things taste or loss of taste
    • Weight loss
    • Tiredness
    • Nausea
    • Diarrhea
    • Decreased appetite
    • Constipation
    • Joint pain
    • Vomiting

Erivedge can cause absence of menstrual periods (amenorrhea) in females who are able to become pregnant. It is not known if amenorrhea is permanent. Talk to your healthcare provider if you have concerns about fertility.

These are not all of the possible side effects of Erivedge. Because everyone is different, it is not possible to predict what side effects any one person will have or how severe they may be. Call your doctor for medical advice about side effects.

You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555.

Please see full Prescribing Information for additional Important Safety Information, including serious side effects, and the Medication Guide.